InvestorsHub Logo
Followers 4
Posts 104
Boards Moderated 0
Alias Born 02/11/2016

Re: None

Sunday, 02/26/2017 2:59:15 AM

Sunday, February 26, 2017 2:59:15 AM

Post# of 1319
Good data contributions, Xena. I assume there are a lot of new shareholders, of which I am one (as may you as well.)

I took my full position all at once mid Friday, figuring we were close enough to the low (turned out to be the actual low,) and then I would sort out going forward whether the market was pricing the commercial prospects too low.

As you suggest, this is one heck of a weird situation...meets a primary endpoint; will get FDA approval for near certain; and yet ex-cash market value of the company falls from $5 to $2....

The company has done a miserable job of preparing shareholders for the commercial prospects, and that leaves mostly retail shareholders to trying to sort it out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TRVN News